tradingkey.logo
tradingkey.logo
Search

Moderna Announces Positive Prelim Immunogenicity Data For 2025-2026 Formula Of mNEXSPIKE

ReutersSep 23, 2025 12:41 PM
facebooktwitterlinkedin
View all comments0

- Moderna Inc MRNA.O:

  • MODERNA: POSITIVE PRELIM IMMUNOGENICITY DATA FOR 2025-2026 FORMULA OF MNEXSPIKE, WHICH TARGETS LP.8.1 VARIANT OF SARS-COV-2

  • MODERNA: PRELIM ANALYSIS SHOWED 2025-2026 FORMULA OF MNEXSPIKE GENERATED >16-FOLD INCREASE IN LP.8.1-NEUTRALIZING ANTIBODIES ACROSS AGE GROUPS

  • MODERNA: SAFETY PROFILE OF VACCINE CONSISTENT WITH PREVIOUS STUDIES

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI